Prothena Corp PLC (PRTA)

55.15
2.12 4.00
NASDAQ : Health Care
Prev Close 53.03
Open 53.84
Day Low/High 51.50 / 55.15
52 Wk Low/High 28.20 / 76.42
Volume 347.68K
Avg Volume 267.10K
Exchange NASDAQ
Shares Outstanding 38.02M
Market Cap 2.19B
EPS -4.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Prothena Raises $155.3M to Bring Anti-Organ Failure Drug to Market

Prothena Raises $155.3M to Bring Anti-Organ Failure Drug to Market

The biotech company plans to commercialize its treatment for AL amyloidosis, a disease that causes protein to build up in the blood.

Biotech Premarket Movers: Karyopharm, Lexicon, Prothena

Biotech Premarket Movers: Karyopharm, Lexicon, Prothena

Karyopharm Therapeutics falls 18%; Lexicon rises on drug approval.

First-In-Human Assessment Of PRX002, Prothena's Anti-Alpha Synuclein Antibody For Parkinson's Disease, Published In Movement Disorders Journal

First-In-Human Assessment Of PRX002, Prothena's Anti-Alpha Synuclein Antibody For Parkinson's Disease, Published In Movement Disorders Journal

Data Previously Presented in 2015 at 19th International Congress of Parkinson's Disease and Movement Disorders